{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T11:26:34Z","timestamp":1774351594915,"version":"3.50.1"},"reference-count":81,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2014,12,11]],"date-time":"2014-12-11T00:00:00Z","timestamp":1418256000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100015606","name":"Wyeth Pharmaceuticals","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015606","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2015,2]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The use of sirolimus\u2010based immune suppression in liver transplantation, particularly in hepatitis C virus (\n                      <jats:styled-content style=\"fixed-case\">HCV<\/jats:styled-content>\n                      )\u2010infected recipients, remains contentious. There is some evidence that sirolimus retards hepatic fibrosis, is renal sparing and may be of benefit in preventing hepatocellular carcinoma (\n                      <jats:styled-content style=\"fixed-case\">HCC<\/jats:styled-content>\n                      ) recurrence. Sirolimus has not been adopted by many transplant centres because of persistent concerns regarding an increased risk of hepatic artery thrombosis, graft loss and death with\n                      <jats:italic>de novo<\/jats:italic>\n                      sirolimus.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>\n                      To review the impact of switching to sirolimus monotherapy in\n                      <jats:styled-content style=\"fixed-case\">HCV<\/jats:styled-content>\n                      \u2010infected liver recipients with respect to survival, graft loss and hepatic fibrosis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A retrospective review of 190 patients from a single centre undergoing first liver transplantation for\n                      <jats:styled-content style=\"fixed-case\">HCV<\/jats:styled-content>\n                      over 15\u00a0years. 113 patients were switched from calcineurin inhibitor (\n                      <jats:styled-content style=\"fixed-case\">CNI<\/jats:styled-content>\n                      )\u2010based therapy to low\u2010dose sirolimus monotherapy at a median of 15\u00a0months after transplantation for\n                      <jats:styled-content style=\"fixed-case\">HCV<\/jats:styled-content>\n                      \u2010related fibrosis (72%), renal impairment (14%) or high\u2010risk\n                      <jats:styled-content style=\"fixed-case\">HCC<\/jats:styled-content>\n                      (5%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Patients switched to sirolimus had improved survival (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0&lt;\u00a00.001) and slower progression to cirrhosis (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00.001). In patients with\n                      <jats:styled-content style=\"fixed-case\">HCC<\/jats:styled-content>\n                      (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a091), sirolimus duration rather than strategy was an independent predictor of survival (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00.001) and extended time to\n                      <jats:styled-content style=\"fixed-case\">HCC<\/jats:styled-content>\n                      recurrence (33 vs. 16\u00a0months). Patients switched for renal dysfunction showed improvement in serum creatinine (140\u2013108\u00a0\u03bcmol\/L,\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00.001). Those remaining on\n                      <jats:styled-content style=\"fixed-case\">CNI<\/jats:styled-content>\n                      \u2010therapy were more likely to develop post\u2010transplant diabetes (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00.03).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      These data suggest selective switching to low\u2010dose sirolimus monotherapy in\n                      <jats:styled-content style=\"fixed-case\">HCV<\/jats:styled-content>\n                      \u2010positive liver recipients improves clinical outcome.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/apt.13049","type":"journal-article","created":{"date-parts":[[2014,12,11]],"date-time":"2014-12-11T06:02:22Z","timestamp":1418277742000},"page":"379-392","source":"Crossref","is-referenced-by-count":8,"title":["A retrospective 15\u2010year review: survival advantage after switching to sirolimus in hepatitis C virus infected liver graft recipients"],"prefix":"10.1111","volume":"41","author":[{"given":"M.","family":"Shah","sequence":"first","affiliation":[{"name":"Division of Gastroenterology and Hepatology Department of Medicine University of Cambridge Cambridge University Hospitals Cambridge UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Shankar","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology Department of Medicine University of Cambridge Cambridge University Hospitals Cambridge UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Gee","sequence":"additional","affiliation":[{"name":"Worcestershire Royal Hospital Worcester UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Nash","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology Department of Medicine University of Cambridge Cambridge University Hospitals Cambridge UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Hoare","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology Department of Medicine University of Cambridge Cambridge University Hospitals Cambridge UK"},{"name":"CRUK Cambridge Institute University of Cambridge Cambridge UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Gibbs","sequence":"additional","affiliation":[{"name":"Department of Surgery Cambridge University Hospitals University of Cambridge Cambridge UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Davies","sequence":"additional","affiliation":[{"name":"Department of Histopathology Cambridge University Hospitals, University of Cambridge Cambridge UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. J. M.","family":"Alexander","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology Department of Medicine University of Cambridge Cambridge University Hospitals Cambridge UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,12,11]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2000.17924"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199603283341302"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/lt.21123"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.33993"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2006.05.001"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/lt.21117"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(00)80231-7"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2007.00920.x"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2007.02126.x"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2005.08.004"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2008.05.002"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0192-0561(99)00005-3"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.2009.00893.x"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/lt.22417"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2007.07.023"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3181fa93fa"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009815"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/lt.21760"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1053\/jlts.2000.19023"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(03)00234-3"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199902270-00002"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1053\/jlts.2003.50268"},{"key":"e_1_2_8_24_1","unstructured":"FDA.Information for Healthcare Professionals: Sirolimus (marketed as Rapamune) U.S Food and Drug Administration: U.S Food and Drug Administration 2009. Available at:http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/DrugSafetyInformationforHeathcareProfessionals\/ucm165015.htm(accessed 23\/08\/2014)."},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12543"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/lt.20237"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-0012.16.s7.7.x"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/lt.21116"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2009.03.018"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3181fe131b"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23835"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(03)00244-6"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2005.12.023"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature08221"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1474-9726.2012.00832.x"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/60.3.293"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M401238200"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2004030180"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI10531"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M606366200"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.10.044"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/201019"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2011.03767.x"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2007.131730"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(03)00191-0"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2010.05.006"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/lt.23658"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1053\/jlts.2001.23012"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/lt.23479"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2011.03919.x"},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(03)00217-3"},{"key":"e_1_2_8_52_1","doi-asserted-by":"publisher","DOI":"10.1053\/jlts.2003.50079"},{"key":"e_1_2_8_53_1","doi-asserted-by":"publisher","DOI":"10.1053\/jlts.2001.26510"},{"key":"e_1_2_8_54_1","doi-asserted-by":"publisher","DOI":"10.1002\/lt.21420"},{"key":"e_1_2_8_55_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0012.2006.00653.x"},{"key":"e_1_2_8_56_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000262607.95372.e0"},{"key":"e_1_2_8_57_1","doi-asserted-by":"publisher","DOI":"10.1002\/lt.21953"},{"key":"e_1_2_8_58_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23437"},{"key":"e_1_2_8_59_1","doi-asserted-by":"publisher","DOI":"10.1002\/lt.22441"},{"key":"e_1_2_8_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2013.04.011"},{"key":"e_1_2_8_61_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12881"},{"key":"e_1_2_8_62_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03343761"},{"key":"e_1_2_8_63_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2007111202"},{"key":"e_1_2_8_64_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e318279090c"},{"key":"e_1_2_8_65_1","doi-asserted-by":"publisher","DOI":"10.6002\/ect.2011.0086"},{"key":"e_1_2_8_66_1","doi-asserted-by":"publisher","DOI":"10.1002\/lt.21314"},{"key":"e_1_2_8_67_1","doi-asserted-by":"publisher","DOI":"10.1002\/lt.20072"},{"key":"e_1_2_8_68_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2007.03364.x"},{"key":"e_1_2_8_69_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2010.04505.x"},{"key":"e_1_2_8_70_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12764"},{"key":"e_1_2_8_71_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12601"},{"key":"e_1_2_8_72_1","doi-asserted-by":"publisher","DOI":"10.1139\/y77-007"},{"key":"e_1_2_8_73_1","first-page":"544","article-title":"Inhibition of T and B lymphocyte proliferation by rapamycin","volume":"72","author":"Kay JE","year":"1991","journal-title":"Immunology"},{"key":"e_1_2_8_74_1","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glq178"},{"key":"e_1_2_8_75_1","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2010.091050"},{"key":"e_1_2_8_76_1","doi-asserted-by":"publisher","DOI":"10.4161\/cc.10.24.18486"},{"key":"e_1_2_8_77_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature07976"},{"key":"e_1_2_8_78_1","doi-asserted-by":"publisher","DOI":"10.2337\/db07-0922"},{"key":"e_1_2_8_79_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2005050487"},{"key":"e_1_2_8_80_1","doi-asserted-by":"publisher","DOI":"10.1210\/edrv.23.2.0461"},{"key":"e_1_2_8_81_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1999.00481.x"},{"key":"e_1_2_8_82_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3313"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fapt.13049","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/apt.13049","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T14:13:37Z","timestamp":1696515217000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/apt.13049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,11]]},"references-count":81,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["10.1111\/apt.13049"],"URL":"https:\/\/doi.org\/10.1111\/apt.13049","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725277034.793502521","asserted-by":"object"}]},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,11]]}}}